Literature DB >> 11171662

Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection.

M M Hagan1, P A Rushing, S C Benoit, S C Woods, R J Seeley.   

Abstract

Agouti-related peptide (AgRP) is a receptor antagonist of central nervous system (CNS) melanocortin receptors and appears to have an important role in the control of food intake since exogenous CNS administration in rats and overexpression in mice result in profound hyperphagia and weight gain. Given that AgRP is heavily colocalized with neuropeptide Y (NPY) and that orexigenic effects of NPY depend on activity at opioid receptors, we hypothesized that AgRP's food-intake effects are also mediated by opioid receptors. Subthreshold doses of the opioid receptor antagonist naloxone blocked AgRP-induced intake when given simultaneously but not 24 h after AgRP injection. Opioids not only influence food intake but food selection as well. Hence, we tested AgRP's effect to alter food choice between matched diets with differing dietary fat content. AgRP selectively enhanced intake of the high-fat but not the low-fat diet. Additionally, AgRP selectively increased chow intake in rats given ad libitum access to a 20% sucrose solution and standard rat chow. The current results indicate that AgRP influences not only caloric intake but food selection as well and that the early effects of AgRP depend critically on an interaction with opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171662     DOI: 10.1152/ajpregu.2001.280.3.R814

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  31 in total

1.  Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system.

Authors:  Ling Lin; Miejung Park; David A York
Journal:  Peptides       Date:  2006-11-17       Impact factor: 3.750

2.  The melanocortin antagonist AgRP (83-132) increases appetitive responding for a fat, but not a carbohydrate, reinforcer.

Authors:  Andrea L Tracy; Deborah J Clegg; Jeffrey D Johnson; T L Davidson; Stephen C Benoit
Journal:  Pharmacol Biochem Behav       Date:  2007-12-23       Impact factor: 3.533

Review 3.  The hormonal signature of energy deficit: Increasing the value of food reward.

Authors:  Sarah H Lockie; Zane B Andrews
Journal:  Mol Metab       Date:  2013-08-19       Impact factor: 7.422

4.  Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin.

Authors:  Amparo Romero-Picó; Maria J Vázquez; David González-Touceda; Cintia Folgueira; Karolina P Skibicka; Mayte Alvarez-Crespo; Margriet A Van Gestel; Douglas A Velásquez; Christoph Schwarzer; Herbert Herzog; Miguel López; Roger A Adan; Suzanne L Dickson; Carlos Diéguez; Rubén Nogueiras
Journal:  Neuropsychopharmacology       Date:  2013-01-24       Impact factor: 7.853

Review 5.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 6.  The MC4 receptor and control of appetite.

Authors:  R A H Adan; B Tiesjema; J J G Hillebrand; S E la Fleur; M J H Kas; M de Krom
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

7.  Preference for a high fat diet, but not hyperphagia following activation of mu opioid receptors is blocked in AgRP knockout mice.

Authors:  Maria J Barnes; George Argyropoulos; George A Bray
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

8.  Control elements in the neighboring ATPase gene influence spatiotemporal expression of the human agouti-related protein.

Authors:  Olha Ilnytska; Mehmet A Sözen; Rachel Dauterive; George Argyropoulos
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

9.  The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women.

Authors:  Lu Qi; Peter Kraft; David J Hunter; Frank B Hu
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

10.  Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats.

Authors:  Stefany D Primeaux; Christine Blackmon; Maria J Barnes; H Douglas Braymer; George A Bray
Journal:  Peptides       Date:  2008-08-13       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.